Aurora (TSX:ACB) Has Sunk From a $7.62 Billion Market Cap in 2019 to $2.4 Billion Today

Disaster struck Aurora Cannabis stock and caused a steep market value drop of $5 billion in less than a year. The weed stock is a risky buy given the formidable challenges ahead.

| More on:
Economic Turbulence

Image source: Getty Images

Industry-wide carnage instead of a boom in 2019 dealt a crushing blow to cannabis producers. The sector’s acknowledged production leader in particular tanked at blinding speed and lost value as a result.

As of this writing, Aurora Cannabis (TSX:ACB)(NYSE:ACB) is trading at $2.06 per share, and the market capitalization stands at only $2.4 billion. In August 2019, Aurora was a top-tier marijuana player, carrying a market cap of $7.62 billion. A series of unfortunate events led to 68.5% ($5.22 billion) drop to its current value.

Tight pathway to profitability

At present, Aurora Cannabis is sinking deeper. The net loss of the Edmonton, Alberta-based company in Q2 fiscal 2020 ended December 31, 2019, was $1.3 billion — $1.18 per share. Goodwill and asset impairment charges amounted to $775 million. The net loss in the year-earlier period was only $182 million.

Aurora is far from attaining profitability, as the pathway is very tight. Its banking syndicate had to cut the company’s $360 million credit line by $141.5 million, or 39.3%. There’s a condition that Aurora should at least hit a level of positive earnings by Q1 fiscal 2021.

Last year, Aurora’s chief corporate officer Cam Battley said that the company would realize substantial profits no sooner than June 30, 2021.

Industry challenges

In fairness, Aurora is not the only cannabis producer facing difficulties. The Canadian industry is still lacking in retail locations. Consumer demand is also shifting, and bulk buying by provinces remains erratic. Aurora cited the volatile ordering patterns by the buyers of second-generation products such as edibles, beverages, and vapes.

Leadership changes and workforce retrenchment are occurring inside Aurora. The company is without a head following the announced retirement of Chief Executive Terry Booth. Michael Singer is the acting CEO, while the termination of 500 employees is part of the cost-saving measures.

Call for patience

Interim CEO Michael Singer is asking investors to be patient. He said that Aurora Cannabis is still evolving with the weed market in Canada. Singer is reminding investors that the Canadian consumer market is only over one year old and needs time to develop.

But the company is extremely bullish on the long-term potential of the Canadian medical and consumer markets. The specific targets are the established international medical markets.

Many investors in the cannabis space are disillusioned, if not furious. Aurora Cannabis made promises that it was not able to deliver. No one is buying the sales pitch anymore.

A valuable lesson to investors

The pressure on Aurora Cannabis is winning back the trust of investors. It has to make significant operational changes and show profits soon to rebuild trust.

Sadly, the task at hand appears daunting. The company needs to add more to its $156 million in cash as of December 31, 2019, to continue operating. About $345 million of convertible bonds are falling due on February 24, 2024.

The consolation from the plight of Aurora Cannabis is the valuable lesson it imparts to investors. A popular stock doesn’t guarantee superior returns. This weed stock is a huge disappointment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »